Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-08-19
    E.g., 2018-08-19

Archive Search

5 results
12:00 AM, Jul 25, 2016  |  BioCentury | Regulation

Salvage in psoriasis?

Weinberg have been investigators for brodalumab and other anti-IL-17 mAbs; Green and Evans have not. Kyowa Hakko Kirin
N.Y. The Johns Hopkins University , Baltimore, Md. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Kyowa Hakko Kirin
12:00 AM, Mar 30, 2015  |  BioCentury | Regulation

China gears up for biosimilars

for about 70% less than originator product Epogen, developed by Amgen Inc. and marketed by Kyowa Hakko Kirin
Beijing, China GeneScience Pharmaceuticals Co. Ltd., Jilin, China Fountain Medical Development Ltd., Beijing, China Kyowa Hakko Kirin
12:00 AM, May 19, 2014  |  BioCentury | Regulation

Beyond vasodilators in PAH

vasodilators. Reata granted AbbVie Inc. ex-U.S. rights to bardoxolone outside of some Asian markets, where Kyowa Hakko Kirin
Indianapolis, Ind. Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Kyowa Hakko Kirin
12:00 AM, Mar 11, 2013  |  BioCentury | Regulation

Dissecting Kadcyla

SIX:ROG) GDC-0980 (RG7422) Dual inhibitor of PI3K and mammalian target of rapamycin (mTOR) Ph II Kyowa Hakko Kirin
12:00 AM, Nov 09, 2009  |  BioCentury | Regulation

Dry Run for Bundling

respectively. The DOPPS study is ongoing and is supported by research grants from Amgen and Kyowa Hakko Kirin
California Inc., a subsidiary of Kyowa Hakko Kirin Co. Ltd. According the U.S. Renal Data System (USRDS), the …
Harvard Medical School , Boston, Mass. Hospital of the University of Pennsylvania , Philadelphia, Pa. Kyowa Hakko Kirin